SUBSCRIBE
SUBSCRIBE
News   Drug Development

Bayer AG. Johnson & Johnson Anti-Clot Drug Gets Cautious Journal Welcome

August 11, 2011 | 
1 min read
An anti-clotting pill from Bayer and Johnson & Johnson offers a new way of preventing stroke although further studies will be needed to refine treatment options, according to a review in a top medical journal.
Clinical research Postmarket research
Johnson & Johnson Family of Companies
MORE ON THIS TOPIC
Illustration of man walking in the beach between two blue seas, surreal abstract path concept
Rare disease
FDA’s Bespoke Pathway To Focus on Gene Editing and RNA-Based Treatments for Rare Diseases
February 23, 2026
 · 
3 min read
 · 
Nick Paul Taylor
Concept of saving money with a pink colored piggy bank held in a hand in front of a blackboard with hand drawn coins
Weight loss
Novo’s CagriSema Falls to Lilly’s Zepbound in Daring Head-to-Head Test
February 23, 2026
 · 
4 min read
 · 
Annalee Armstrong
Insights
Historic ALS Investment Signals New Treatment Momentum
February 23, 2026
 · 
3 min read
 · 
Jennifer Smith-Parker
Human hands holding colorful pieces of puzzle. Vector hand drawn sketch illustration. Business team solving problem, joining and connecting jigsaw. Teamwork, partnership, business solution concept
MASH
Beyond Rezdiffra: The 4 Most Promising MASH Pipelines in Play
February 23, 2026
 · 
6 min read
 · 
Ben Hargreaves